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Abstract:  5	  
Phytate and mineral cations are both considered as important dietary factors for inhibiting the 6	  
crystallisation of calcium oxalate kidney stones in susceptible individuals. In this paper, the 7	  
phytate and mineral composition of whole bran cereals (wheat, barley and oat) and legumes were 8	  
determined together with their soluble and insoluble oxalate concentrations in order to 9	  
investigate the effects on oxalate solubility. The oat bran sample had the highest soluble oxalate 10	  
concentration at 79 ± 1.3 mg/100g, while total and soluble oxalate concentrations in the food 11	  
samples studied range from 33-199 mg/100 g and 14-79 mg/100 g, respectively. The phytate 12	  
concentration was in the range from 227-4393 mg/100 g and the concentrations of cations were 13	  
in the range 54-70 mg/100g for calcium, 75-398 mg/100g for magnesium, 244-1529 mg/100g for 14	  
potassium and 4-11 mg/100g for iron. Soluble oxalate concentration did not increase in 15	  
proportion to total oxalate, and the phytate concentration in all foods was sufficient to contribute 16	  
to an increase in soluble oxalate concentration by binding calcium. 17	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1. Introduction   20	  
The availability of soluble oxalate from food has been considered to be one of the main 21	  
contributors to the development of hyperoxaluria, which is the excessive urinary excretion of 22	  
oxalate (Holmes, Goodman, Assimos, & Winston-Salem, 1996). Hyperoxaluria can lead to 23	  
deposition of calcium oxalate (oxalosis) in kidney tissue or crystallisation as calcium oxalate 24	  
kidney stones (nephrolithiasis) in the urinary tract (Sanz & Reig, 1992). Foods with oxalate 25	  
levels greater than 50 mg/100 g are categorized as high oxalate foods, and these include whole 26	  
bran cereals and legumes (Boontaganon, Jéhanno, & Savage, 2009; Chai & Liebman, 2005).  27	  
Oxalate absorption usually depends on the presence of free or soluble oxalate in the intestine 28	  
(Brinkley, MgGuire, Gregory, & Pak, 1981). It has been reported that soluble oxalate is totally 29	  
released from bran at gastrointestinal pH, but it can combine with calcium already available in 30	  
the bran sample to form the insoluble salt (Siener, Heynck, & Hesse, 2001). It is therefore 31	  
important when assessing intake of oxalate to consider the balance of soluble to insoluble forms 32	  
of oxalate available from foods. 33	  
A main factor that regulates soluble oxalate is the concentration of divalent cation minerals, 34	  
including calcium and magnesium (Reddy, Sathe, & Salunkhe, 1982). The presence of cations in 35	  
the gut has been found to interfere with oxalate absorption. Higher concentrations of cations like 36	  
calcium and, to a lesser extent, magnesium have been found to decrease oxalate absorption, and 37	  
their concentration in simultaneously ingested foods has therefore been considered as important 38	  
with respect to kidney stone formation (Asplin, 2002). The solubility of calcium oxalate is 39	  
strongly pH dependent with solubility increasing strongly below pH 4 (Jaeger & Robertson, 40	  
2004). Magnesium oxalate is more soluble than calcium oxalate, 0.07 g / 100 ml versus 0.0007 41	  
g/100 ml respectively, but it still contributes to insoluble oxalate in the gut, when its 42	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concentration exceeds the solubility limit (Tiselius, 1991). The solubility product constant for 43	  
magnesium oxalate at pH 7 has been reported as 8.5x10-5 mol2. dm-6, compared to 2.7x10-9 mol2. 44	  
dm-6 for calcium oxalate (University of Rhode Island, 2001),	  although the solubility in urine is 45	  
more complex, since calcium oxalate crystals can occur as mixtures differing in the degree of 46	  
hydration (Streit, Tran-Ho, & Königsberger, 1998).	  It has been suggested that magnesium may 47	  
have a small effect on oxalate uptake by complexing oxalate and making it less available for 48	  
absorption (Jaeger & Robertson, 2004).  However, magnesium supplementation also has been 49	  
reported to have no effect on urinary oxalate level (Allie & Rodgers, 2003). Phytate is also 50	  
considered as beneficial with respect to nephrolithiasis due to its antioxidant properties (Graf & 51	  
Eaton, 1990), although more recently phytate was found to increase soluble oxalate available for 52	  
absorption as well as recurrence of kidney stones as a consequence of its combination with 53	  
calcium in the human gut (Al-Wahsh, 2005). Cereals and legumes have been found to contain 54	  
high concentrations of phytate (Reddy et al., 1982), which makes it an important factor to 55	  
consider when evaluating these foods for oxalate. 56	  
The molar ratio of oxalate to concurrent minerals has been used as a measure of the availability 57	  
of oxalate for absorption. Molar ratios of oxalate to minerals greater than 2 and phytate to 58	  
minerals greater than 0.24 have been reported as hazardous (Fassett, 1973; Reddy & Sathe, 59	  
2002). This study aimed to investigate the molar ratio of oxalate and phytate to concurrent 60	  
minerals in common plant materials in order to assess the availability of oxalate for absorption. 61	  
Few studies on the effect of a combination of oxalate and phytate on the availability of oxalate 62	  
and its influence on kidney stones have been reported. Although bran and beans are common 63	  
dietary components, the concentrations of phytate and oxalate in the same samples of these foods 64	  
have not been reported. The aim of this study was to investigate the effects of oxalate, phytate 65	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and mineral concentrations on oxalate solubility in order to predict its bioavailability.  These 66	  
findings would allow conclusions to be drawn about the influence of these foods on the risk of 67	  
hyperoxaluria in susceptible subjects.  68	  
2. Materials and methods  69	  
2.1. Food samples  70	  
Whole bran cereals (wheat bran, barley bran and oat bran) were obtained from Premier Foods, 71	  
UK. Legumes (red beans and white beans) imported from Spain were purchased at a local 72	  
market.  One batch of each foodstuff was purchased for analysis. 73	  
2.2.Oxalate analysis  74	  
Oxalate was extracted by a method based on that described by (Savage, Vanhanen, Mason, & 75	  
Ross, 2000).  76	  
Samples (1 g) were extracted with 50 ml 1.0 M H2SO4 at 21°C for 15 min in a shaking water 77	  
bath. The extracts were transferred into a 100 ml volumetric flask, and made to volume with 1.0 78	  
M H2SO4 for total oxalate and with distilled water for soluble oxalate. The dissolved oxalate 79	  
solution was separated by centrifugation at 3000 rpm for 15 min and passed through a 0.45 µm 80	  
nylon syringe filter. The oxalate concentration in each sample was determined by HPLC using an 81	  
Agilent 1100 series chromatograph with autosampler, isocratic pump and UV/VIS detector set at 82	  
210 nm. Data capture and analysis were done by using Chemstation software Version A-7.1. A 5 83	  
µl injection volume was used with an Aminex Ion exclusion HPX-87H 300 × 7.8 mm analytical 84	  
column fitted with an Aminex Cation-H guard column. Isocratic elution was used with 0.0125 M 85	  
H2SO4 (Sigma Aldrich, UK) as mobile phase and a flow of 0.5 ml/min. The analytical column 86	  
was held at 65°C, and the column was equilibrated with a flow rate of 0.2 ml/min prior to use.  87	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2.3.Phytate analysis  88	  
 Phytate was extracted by the method described by (Oberleas & Harland, 2007). Finely ground 89	  
dried sample (1 g) was extracted with 10 ml of 0.66 M HCl with gentle agitation for 3 h on a 90	  
shaking mixer. The sample was centrifuged at 3500 rpm for 10 min, and the supernatant was 91	  
filtered through a 0.45 µm syringe filter into an HPLC vial.  92	  
The sample was analyzed by HPLC using an Agilent 1050 series chromatograph consisting of 93	  
two pumps, UV-Vis detector, set at 500 nm and Chemstation software Version A-8.3. The 94	  
column was a strong anion-exchange type, Polymer Laboratories PL-Sax 5 × 0.46 cm, particle 95	  
size 8 µm and 100 nm pore size (Varian, Inc.Shropshire, UK). A flow rate of 1 ml/min was used 96	  
for the mobile phase and 0.5 ml/min was used for Wade’s reagent. The injection volume was 5 97	  
µl. The analytical column was kept at room temperature and equilibrated with 0.01 M methyl 98	  
piperazine at pH 4 as mobile phase with a flow rate of 0.2 ml/min before analysis of the sample. 99	  
The gradient buffer was 0.6 M sodium nitrate in 0.01 M methyl piperazine at pH 4. Phytate 100	  
concentration was calculated using 660 g mol-1 as the hexaphosphate molecular weight as 101	  
recommended by  (Oberleas & Harland, 2001).  102	  
2.4. Mineral analysis  103	  
Calcium, magnesium, potassium and iron were analyzed by atomic absorption 104	  
spectrophotometry at 422.7, 285.2, 766.5 and 248.3 nm respectively (Analytik Jena 105	  
AG,Germany Model NovAA® 350) (Analysis of agriculture materials, 1986). 106	  
2.5. Statistical analysis  107	  
Results are presented as means of triplicate determinations ± S.E M. Significant differences 108	  
between samples (p<0.05) were identified by Analysis of Variance (ANOVA) with the Tukey 109	  
HSD test. The analysis was carried out with SPSS version 18.   110	  
6	  
	  
3. Results and discussion  111	  
3.1. Oxalate  112	  
The total oxalate content of wheat bran, oat bran and red beans is shown in Table 1. The oxalate 113	  
content for intake of 100 g of test food samples is high compared to the maximum recommended 114	  
daily intake of oxalate from food which is 40-50 mg/day (American dietetics association, 2005). 115	  
The total oxalate content was in the order wheat bran > oat bran > red bean >> barley bran > 116	  
white bean. However, only soluble oxalate is absorbed, and the soluble oxalate fell in the order 117	  
oat bran > wheat bran > barley bran > red bean > white bean. Thus, it is clear that the cereal bran 118	  
samples contained a higher concentration of soluble oxalate than the legume samples. The 119	  
oxalate content for these foods was within the range reported in the literature (Siener, Hönow, 120	  
Seidler, Voss, & Hesse, 2006);,(Chai & Liebman, 2005); and (Boontaganon et al., 2009) . 121	  
3.2. Cations  122	  
Oxalate absorption is highly dependent on the availability of the soluble form. Potassium oxalate 123	  
is an important soluble form for absorption (Brinkley et al., 1981).The proximal small intestine is 124	  
a major site for absorption of oxalate (Hanes, Weaver, Heaney, & Wastney, 1999), but changes 125	  
of pH throughout the gastrointestinal tract also have an effect on the absorption of oxalate. 126	  
Oxalate is more soluble under the acid conditions of the stomach, which ranges from pH 1.5-2, 127	  
than at higher pH, so insoluble oxalate forms again after passing into the alkaline environment of 128	  
the small intestine. Thus oxalate which has been solubilised in the stomach will form a sparingly 129	  
soluble complex again with calcium, magnesium and iron in the intestine. Soluble oxalate is 130	  
available for absorption from the intestine through the mucosa (Savage & Catherwood, 2007). 131	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 Calcium is the main cation that forms an insoluble complex with oxalate, and thereby reduces 132	  
absorption from the gut (Benitez, Grijalva, & Valencia, 1994). Ferrous oxalate is similar in 133	  
solubility to calcium oxalate, so ferrous ions may contribute to a reduction in soluble oxalate, 134	  
and iron was identified as a metal that may promote the formation of calcium oxalate stones, 135	  
whereas magnesium was considered as an inhibitor (Atakan et al., 2007). The range of mineral 136	  
concentrations in the food samples tested was 23-70 mg/100 g for calcium, 75-398 mg/100 g for 137	  
magnesium, 244-1382 mg/100 g for potassium and 4-11 mg/100 g for iron (Table 2). 138	  
3.3. Molar ratio of oxalate and minerals  139	  
The presence of cations in foods eaten at the same time as sources of oxalate is highly important 140	  
for determining the relative concentrations of soluble and insoluble oxalate (Asplin, 2002). 141	  
Therefore, the potential of foods for contributing to soluble oxalate is best assessed in terms of 142	  
the oxalate: mineral ratio for minerals that form insoluble oxalate complexes. A ratio greater than 143	  
2 indicates that a food contains excess oxalate that is bioavailable, whereas, foods having a ratio 144	  
of 1 or less contain enough calcium, or similar minerals, to minimise formation of soluble 145	  
oxalate (Gontzea & Sutzescu, 1968). The solubility product constant for calcium oxalate was 146	  
reported as 2.7x10-9 mol2 . dm-6 (URI(Chemistry;University of Rhode Island), 2001). The whole 147	  
wheat and oat bran samples studied have a molar ratio of oxalate: calcium greater than 2 as 148	  
shown in Table 3 and the soluble oxalate content is quite high.  In contrast, the molar ratio of 149	  
oxalate: calcium for red kidney beans was 0.91, and the soluble oxalate content was relatively 150	  
low compared to the cereal brans. The soluble oxalate content of white beans and barley bran 151	  
was also low. Magnesium oxalate is more soluble than calcium oxalate with a solubility product 152	  
constant of 8.5x10-5 mol2. dm -6 (URI(Chemistry;University of Rhode Island), 2001), and  it does 153	  
not form stones at physiological urine concentrations. However, the solubility of the magnesium 154	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salt is sufficiently low to reduce dietary oxalate absorption (Liebman & Costa, 2000) (Massey, 155	  
2005) . The molar ratio of oxalate: magnesium was low for all foods studied, but magnesium is 156	  
less effective than calcium in reducing oxalate bioavailability (Brinkley et al., 1981). Potassium 157	  
oxalate is a soluble form, but the potassium concentration was very low in all the samples 158	  
analyzed.  159	  
3.4. Phytate  160	  
The wheat bran sample contained a high concentration of phytate compared to the other food 161	  
samples i.e 4393 ± 1.4 mg/100 g. The barley bran sample contained the lowest concentration of 162	  
phytate, and the phytate concentration in the beans ranged from 610-670 mg/100 g. The phytate 163	  
concentrations were comparable to the values reported in the literature (Kirby & Nelson, 1988); 164	  
(Harland, Oke, & Felix-Phipps, 1988).  165	  
3.5. Molar ratio of phytate and mineral  166	  
Phytate has been considered as beneficial for kidney disease due to its ability to chelate metal 167	  
ions which reduces oxidative reactions (Graf & Eaton, 1990). However, the ability of phytate to 168	  
form insoluble complexes with divalent cations in the human gut has the consequence of 169	  
increasing the availability of soluble oxalate for absorption and urinary excretion (Al-Wahsh, 170	  
2005).  A molar ratio of phytate:calcium > 0.24 has been found to be associated with reduced 171	  
calcium bioavailability (Morris & Ellis, 1985). The solubility product constants for calcium 172	  
phytate and calcium phosphate were reported as 10-22  and 2.07x10-33 mol2. dm -6 respectively 173	  
(Evans & Pierce, 1981; KTF (Chemical Technology Faculty; University of Split), 2003). A high 174	  
molar ratio of phytate: Ca was present in the whole bran samples, so this would increase the 175	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soluble oxalate concentration by reducing the availability of minerals for forming insoluble 176	  
oxalate in the test food samples. 177	  
The molar ratio of Mg: phytate was very low in the test samples ranging from 0.15 to 0.41, and 178	  
this would further reduce any effect of magnesium on soluble oxalate content. 179	  
3.6. Correlation of molar ratio of oxalate, phytate and minerals  180	  
Phytate is known to be effective in chelating minerals. It reduces the availability of complex-181	  
forming minerals in the body and makes oxalate more bioavailable (Brinkley, Gregory, & Pak, 182	  
1990; Harland & Morris, 1995). Ca binding by fibre is low in wheat and oat brans at gastric pH 183	  
(Siener et al., 2001), but calcium absorption from the small intestine after intake of wheat bran 184	  
has been reported to decrease slightly in ileostomy patients, who have had a surgical procedure 185	  
to allow them to excrete waste from the small intestine into an external bag, where it is collected 186	  
(Sandberg, Hasselblad, Hasselblad, & Hultén, 1982). Phytate complexes with Mg are soluble at 187	  
low pH (Grynspan & Cheryan, 1983), but complexes with Ca and Fe are less soluble. In soy 188	  
foods, the content of phytate increased with an increase in oxalate content, so soy foods with a 189	  
low oxalate content were recommended for kidney stone patients (Al-Wahsh, Horner, Palmer, 190	  
Reddy, & Massey, 2005). The wheat bran sample had relatively high insoluble oxalate content 191	  
despite a high concentration of phytate and a low concentration of calcium. The high magnesium 192	  
content of the wheat bran sample may contribute to the high insoluble oxalate content. In the oat 193	  
bran sample, the insoluble oxalate concentration was much reduced compared to the wheat bran 194	  
which is consistent with the low calcium and magnesium concentrations. The molar ratio of 195	  
soluble: insoluble oxalate of oat bran was much higher than for the wheat bran as shown in table 196	  
4. The barley bran sample had a low calcium concentration but a relatively high magnesium 197	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concentration, which is consistent with the values for barley bran reported previously (Dendy & 198	  
Bogdan, 2001). The phytate concentration showed a moderate correlation with the insoluble 199	  
oxalate concentration with an R2 value of 0.46, but the correlation with the soluble: insoluble 200	  
oxalate ratio was poor with R2 <0.01. The beans had lower soluble: insoluble oxalate ratios than 201	  
the brans.  202	  
Conclusion  203	  
High total oxalate and phytate as well as low calcium and magnesium contents contributed to the 204	  
high soluble oxalate content in the oat bran sample. The soluble oxalate concentration was higher 205	  
for the oat bran sample than for the wheat bran sample despite a reverse order for total oxalate, 206	  
and this can be ascribed to the lower concentration of minerals in the oat bran sample, with the 207	  
minerals in the wheat bran contributing to a reduction of soluble oxalate in the wheat bran. All 208	  
the food samples analysed had a phytate: calcium ratio >0.24, so this indicates that the phytate 209	  
concentration is sufficient to reduce the calcium available for binding to oxalate, and thereby 210	  
contributes to an increase in soluble oxalate Soluble oxalate concentration was relatively low in 211	  
the barley bran and red kidney bean samples and was not detected in the white bean sample.  212	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Table 1  310	  
Phytate, and total, soluble and insoluble oxalate in food samples (mg/100 g dry weight ± 311	  
SEM). 312	  





Wheat Bran	   199 ± 3.5c 56 ± 4.2c 146 ±1.8d	   4393 ± 1.4d	  
Oat Bran	   159 ±1.6b 79 ± 1.3d 80 ± 4.3b	   992 ± 1.2c 
Barley Bran	   47 ± 1.4a 21 ± 1.4b 26 ± 1.0a	   227 ± 0.4a	  
Red Kidney Bean	   146 ± 1.6b 25± 1.2b 121 ± 1.2c	   616 ± 0.3b	  
White Bean	   33 ± 2.8a nda 33 ± 2.0a	   671 ± 1.3bc 
Results are presented as Mean ± SEM of triplicate determinations 313	  
Nd = not detected;concentration < 0.01 mg/100 g  314	  
a-d Numbers with different superscripts in the same column are significantly different (p<0.05)315	  
14	  
	  
Table 2  316	  
Calcium, magnesium, potassium and iron from test food samples (mg/100 g dry weight ± 317	  
SEM). 318	  
Sample Calcium Magnesium Potassium Iron 
Wheat Bran	   30 ±1.6b 398±2.5b 1529±1.9c 11±4.2c 
Oat Bran	  
23±2.1a 
118 ±3.6a 377 ±1.6a 4 ±0.4a 
Barley Bran	  
55 ±2.1c 
75 ±1.9a 244±0.2a 7±0.6b 
Red Bean	  
70±1.7d 
114 ±1.5a 984±1.5b 6 ±0.2ab 
White Bean	  
54±0.3c 
166 ±2.5a 914±3.0b 8±0.2b 
Results are presented as Means±SEM and each sample was analyzed as triplicate  319	  




Table 3  322	  
Molar ratio of oxalate: minerals and phytate: minerals.   323	  
Test Samples 
Parameters Wheat Bran Oat Bran Barley Bran Red Kidney Bean White Bean  
Oxalate: Calcium 3.02 3.14 0.40 0.95 0.28 
Oxalate: Magnesium 0.14 0.37 0.17 0.34 0.05 
Oxalate: Potassium 0.06 0.19 0.09 0.06 0.02 
Oxalate: Iron 11.13 23.89 4.23 12.04 3.10 
Phytate: Calcium 8.89 2.61 0.26 0.53 0.76 
Phytate: Magnesium 0.41 0.31 0.11 0.20 0.15 
Phytate: Potassium 0.17 0.16 0.06 0.04 0.04 












Table 4   333	  
Molar ratios of phytate with calcium and magnesium and its correlation with soluble: 334	  

















1 Wheat Bran 6.65 0.74 16.36 17.1 0.40 0.38 
2 Oat Bran 1.5 0.57 4.87 5.44 0.28 0.99 
3 Barley Bran 0.34 1.34 3.07 4.41 0.08 0.81 
4 Red Bean 0.93 1.74 4.7 6.44 0.14 0.21 
5 White Bean 1.01 1.34 6.84 8.18 0.12 0* 
 336	  
*Soluble oxalate < 0.01mg/100g, so the ratio is < 0.001.  337	  
 338	  
	  339	  
